Cara Therapeutics Study Site

New York, New York 10065

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Cholestatic Pruritus, Chronic Kidney Diseases, Notalgia Paresthetica, Pruritus

Studies at this site

• CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus — Stopped early
• Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus — Stopped early
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT) — Completed
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis — Completed